Share on StockTwits

Dolby Laboratories (NYSE:DLB) major shareholder Dagmar Dolby sold 80,000 shares of Dolby Laboratories stock on the open market in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $44.77, for a total value of $3,581,600.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Shares of Dolby Laboratories (NYSE:DLB) traded up 1.45% during mid-day trading on Wednesday, hitting $45.48. The stock had a trading volume of 400,649 shares. Dolby Laboratories has a 52 week low of $31.19 and a 52 week high of $45.83. The stock’s 50-day moving average is $43.69 and its 200-day moving average is $42.47. The company has a market cap of $4.645 billion and a price-to-earnings ratio of 22.40.

Dolby Laboratories (NYSE:DLB) last announced its earnings results on Thursday, July 24th. The company reported $0.38 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.27 by $0.11. The company had revenue of $223.40 million for the quarter, compared to the consensus estimate of $210.23 million. During the same quarter in the prior year, the company posted $0.47 earnings per share. The company’s quarterly revenue was up 7.9% on a year-over-year basis. On average, analysts predict that Dolby Laboratories will post $1.86 earnings per share for the current fiscal year.

A number of research firms have recently commented on DLB. Analysts at Zacks downgraded shares of Dolby Laboratories from an “outperform” rating to a “neutral” rating in a research note on Wednesday, July 30th. They now have a $48.00 price target on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated an “underweight” rating on shares of Dolby Laboratories in a research note on Friday, July 25th. They now have a $43.00 price target on the stock, up previously from $38.00. Finally, analysts at B. Riley initiated coverage on shares of Dolby Laboratories in a research note on Tuesday, July 1st. They set a “neutral” rating and a $41.00 price target on the stock.

Dolby Laboratories, Inc designs and manufactures video and audio products for the film production, cinema, and television broadcast industries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.